Robert Palmason (Former)
1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Allergen-specific human IgE isolated through an allergen-agnostic pipeline—understanding immune response and allergen recognition
- Contribution to journal › Article
-
Mark
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance results from the population-based iStopMM study
(2026) In Blood Cancer Journal
- Contribution to journal › Article
-
Mark
Circulating CAR T-Cells After Treatment With Axicabtagene Ciloleucel in Patients With Relapsed/Refractory Aggressive B-Cell Lymphomas and Its Association to Treatment Outcome
- Contribution to journal › Article
- 2025
-
Mark
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events : Results from iStopMM, a prospective population-based screening study
- Contribution to journal › Article
- 2024
-
Mark
Monoclonal gammopathy of undetermined significance with multiple paraproteins : A population-based screening study
- Contribution to journal › Article
-
Mark
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study
- Contribution to journal › Article
-
Mark
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance : a flow cytometry sub-study of the iStopMM screening study
- Contribution to journal › Article
- 2021
-
Mark
Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation
- Contribution to journal › Article
- 2017
-
Mark
Antibody-encoding repertoires of bone marrow and peripheral blood-a focus on IgE
- Contribution to journal › Letter
- 2015
-
Mark
Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib.
- Contribution to journal › Article
